Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
Code effective Jan 01, 2017
HCPCS Section
Drugs administered other than oral method, chemotherapy drugs
J7301 is a valid 2026 HCPCS code meaning Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg or (Skyla, 13.5 mg) for short. HCPCS J7301 has been effective since 01/01/2017 and applies to Other medical items or services.
|
HCPCS Level II Code Section J - Drugs administered other than oral method, chemotherapy drugs |
|
| HCPCS Code | J7301 |
|---|---|
| Description |
Long description:
Short description: |
| HCPCS Pricing indicator |
00 - Physician Fee Schedule And Non-Physician Practitioners - Service not separately priced by part B (e.g., services not covered, bundled, used by Part A only, etc.)
|
| Multiple pricing indicator |
9 - Not applicable as HCPCS not priced separately by part B or value is not established
|
| Statute number | 1862(a)(1) |
| Coverage code | S - Non-covered by Medicare statute |
| BETOS2 code | P6C - Minor procedures - other (Medicare fee schedule) |
| HCPCS Action code | N - No maintenance for this code |
| Type of service | 9 - Other medical items or services |
| Effective date | Effective Jan 01, 2017 |
| Date added | Added Jan 01, 2014 |
1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).
2 BETOS stands for “Berenson-Eggers Type Of Service”
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026
CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.